摘要
介绍了课题组对贵州苗药——大果木姜子(米槁)进行综合系统研究的情况和方法:首先对大果木姜子进行本草考证;生态资源的调查;同功、易混品种的鉴别;生药学研究等,将大果木姜子开发成一种中药材新品种,已经卫生部门批准。其次,对大果木姜子进行药理、化学成分系统研究。并对大果木姜子进行新产品开发的研究:研制以大果木姜子为主药的中药新药心胃丹胶囊、米槁心乐滴丸、米槁精油滴丸,以及以基地建没为基础的产业化开发。
The conditions and ways in which the research group makes general and systematic study on Cin-namomum Migao H. W. Li (migao) are introduced in this paper. Firstly, textually study, investigation of the zoology resource, identification of the same efficacy and confusion, phannacognostic study have been finished, the results have led the migao to a new Chinese medicinal material, and it has been authorized by the related health service. Secondly, systematically studies of chemical elements and pharmacology have been done. In addition, exploiting and studying of new products of migao: study of the traditional Chinese medicine with the migao as the main element, such as Xinweidan capsule, Migao Xinle Diwan, Migao Jingyou Diwan, and the exploitation of the industrialization based on the base construction.
出处
《中国民族民间医药》
2003年第1期1-5,共5页
Chinese Journal of Ethnomedicine and Ethnopharmacy